We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

160 hedge funds and large institutions have $237M invested in TherapeuticsMD in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 62 increasing their positions, 27 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 27

66% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.54M

20% more capital invested

Capital invested by funds: $197M → $237M (+$39.9M)

13% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 24

1% more funds holding

Funds holding: 159 → 160 (+1)

0.17% less ownership

Funds ownership: 1.09% → 0.91% (-0.17%)

Holders
160
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
2.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
62
Reduced
27
Closed
24
Calls
$2.56M
Puts
$1.54M
Net Calls
+$1.01M
Net Calls Change
+$1.11M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.67M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.71M
3
State Street
State Street
Massachusetts
+$4.31M
4
PA
Perceptive Advisors
New York
+$4.31M
5
Millennium Management
Millennium Management
New York
+$3.99M

Top Sellers

Rank Fund Capital Flow
1
GC
GMT Capital
Georgia
-$7.24M
2
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
-$3.92M
3
Morgan Stanley
Morgan Stanley
New York
-$3.07M
4
RCMNY
Rubric Capital Management (New York)
New York
-$2.7M
5
HI
Handelsinvest Investeringsforvaltning
Denmark
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
126
Zurich Cantonal Bank
Switzerland
$19K – – –
SWP
127
Stratos Wealth Partners
Ohio
$18K – – –
PCA
128
Personal Capital Advisors
California
$18K +$157 +2 +0.8%
MSWMA
129
Market Street Wealth Management Advisors
Indiana
$17K +$20.3K +259 New
PAMU
130
Pictet Asset Management (UK)
United Kingdom
$16K -$38.7K -494 -68%
CA
131
Calton & Associates
Florida
$16K -$3.13K -40 -14%
CIBC Asset Management
132
CIBC Asset Management
Ontario, Canada
$16K +$2.27K +29 +13%
HighTower Advisors
133
HighTower Advisors
Illinois
$16K +$19.3K +247 New
AWE
134
Avidian Wealth Enterprises
Texas
$15K – – –
Osaic Holdings
135
Osaic Holdings
Arizona
$15K +$705 +9 +4%
DI
136
DFPG Investments
Utah
$14K – – –
Bank of Montreal
137
Bank of Montreal
Ontario, Canada
$13K -$744K -9,509 -98%
Walleye Trading
138
Walleye Trading
New York
$13K +$15.7K +200 New
PCM
139
Penserra Capital Management
California
$11K +$2.74K +35 +25%
Northwestern Mutual Wealth Management
140
Northwestern Mutual Wealth Management
Wisconsin
$9K – – –
HNB
141
Huntington National Bank
Ohio
$8K – – –
PNC Financial Services Group
142
PNC Financial Services Group
Pennsylvania
$6K +$3.13K +40 +85%
SFS
143
Sowell Financial Services
Arkansas
$5K – – –
MCM
144
MV Capital Management
Maryland
$3K – – –
Carson Wealth (CWM LLC)
145
Carson Wealth (CWM LLC)
Nebraska
$2K – – –
TWA
146
TCI Wealth Advisors
Arizona
$2K – – –
TFS
147
TrustCore Financial Services
Tennessee
$2K – – –
HI
148
Harbour Investments
Wisconsin
$2K +$2.27K +29 New
BFG
149
Baron Financial Group
New Jersey
$1.07K – – –
SPIA
150
Steward Partners Investment Advisory
New York
$1K – – –
4 5
6
7 8

TXMD Hedge Fund Activity: Q1 2021 in Review

160 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2021, worth a combined $237M — up 20% from $197M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TXMD positions and 24 closed out — a net gain of 3 holders — while 62 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $9.67M. The largest seller was GMT Capital, exiting entirely with an estimated $7.24M sold.

  • 160 institutional investors held TherapeuticsMD (TXMD) as of Q1 2021, up from 159 in Q4 2020.
  • Funds reported $237M of TherapeuticsMD stock for Q1 2021, up 20% quarter-over-quarter.
  • 27 funds opened new TherapeuticsMD positions in Q1 2021 and 24 closed out, a net change of +3 holders.
  • The largest TherapeuticsMD buyer in Q1 2021 was BlackRock, an estimated $9.67M added.
  • The largest TherapeuticsMD seller in Q1 2021 was GMT Capital, an estimated $7.24M sold.

Based on aggregated 13F filings for Q1 2021.